Biotechnology | Healthcare
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Market Cap
414648598528
Current Price
346.1
52 Week Range
291.0 - 404.7
Previous Close
341.2
Open
341.2
Industry
Biotechnology
Sector
Healthcare
Address
20th KM Hosur Road, Electronic City, Bengaluru, 560100, India
Phone
+91-80280-82808
Fax
+91-80285-23423
Website
https://www.biocon.com
Day Low
338.1
Day High
346.4
Dividend Yield
0.15
PE Ratio
40.574444
Earnings Per Share
8.53
Beta
0.219
EBITDA
31662999552
Book Value
180.943
EPS
6.76915
Name | Title | Age | Year Born |
---|---|---|---|
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. | Founder & Executive Chairperson | 71 | 1953 |
Mr. Siddharth Mittal BCom, CA, CPA | MD, CEO & Director | 46 | 1978 |
Mr. Mukesh Kamath | Chief Financial Officer | - | - |
Mr. Arun Gupta | Head of Operations | - | - |
Mr. Atanu Roy | Group Chief Information Officer | - | - |
Mr. Saurabh Paliwal | Head of Investor Relations | - | - |
Ms. Seema Shah Ahuja BA, MBA | Global Head of Communications & Corporate Brand | 58 | 1966 |
Ms. Maninder Kapoor Puri | Head of Human Resources | 51 | 1973 |
Mr. Paul Vazhayil Thomas | Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business | 51 | 1973 |
Mr. Abhijit Zutshi | Commercial Head of Biocon Global Generics | - | - |
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.